In-vitro Disease Model

AI-optimized bioinks are bioprinted into precise three-dimensional tissue architectures.

Cells mature into functional living tissue under controlled culture.

Multiple human cell types interact within the matured tissue to recreate the native disease microenvironment.

The in-vitro disease model is used to evaluate drug efficacy, toxicity, dose response, and therapeutic outcomes, generating predictive human-relevant data before clinical studies.